Ables, Iannone, Moore & Associates, Inc. Johnson & Johnson Transaction History
Ables, Iannone, Moore & Associates, Inc.
- $155 Billion
- Q3 2024
A detailed history of Ables, Iannone, Moore & Associates, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Ables, Iannone, Moore & Associates, Inc. holds 15,954 shares of JNJ stock, worth $2.33 Million. This represents 1.67% of its overall portfolio holdings.
Number of Shares
15,954
Previous 16,077
0.77%
Holding current value
$2.33 Million
Previous $2.35 Billion
10.04%
% of portfolio
1.67%
Previous 1.55%
Shares
4 transactions
Others Institutions Holding JNJ
# of Institutions
4,275Shares Held
1.68BCall Options Held
17.6MPut Options Held
14.5M-
Vanguard Group Inc Valley Forge, PA231MShares$33.7 Billion0.69% of portfolio
-
Black Rock Inc. New York, NY198MShares$28.9 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$19.6 Billion0.9% of portfolio
-
Geode Capital Management, LLC Boston, MA56.1MShares$8.18 Billion0.75% of portfolio
-
Morgan Stanley New York, NY45.2MShares$6.59 Billion0.54% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $381B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...